Jason Brittain has over 25 years of experience with pharmaceutical product development specializing in formulation development and manufacturing of clinical supplies from pre-clinical through commercialization. Throughout his career, Mr. Brittain managed CMC operational activities and strategies for drug substance development/manufacturing, formulation/drug product manufacturing, analytical development/qualification, and labeling / packaging. Mr. Brittain developed and assisted with 10 ANDA parenteral products, the formulator of Treanda® and LIVMARLI®, and the lead small molecule filing of the Japanese approval of Akalux®. Mr. Brittain assisted with multiple CMC technical due diligences for in-licensing and partnering activities throughout his career.